Influenza Hemagglutinin (HA) Peptide: Benchmarks, Mechanism & Applications

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid epitope tag derived from the human influenza virus HA protein, facilitating fusion protein detection and purification with high specificity (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html). This peptide exhibits robust solubility across DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), supporting diverse assay conditions. APExBIO’s HA Peptide (A6004) is supplied at >98% purity, verified by HPLC and mass spectrometry, ensuring performance consistency. The HA tag is widely used in immunoprecipitation (IP) and competitive elution, leveraging its high-affinity interaction with anti-HA antibodies. Benchmarks in recent cancer signaling studies highlight the HA tag’s role in dissecting E3 ligase and ubiquitination pathways (https://doi.org/10.1002/advs.202504704).

Biological Rationale

The HA tag is derived from the influenza virus hemagglutinin protein, specifically the amino acid sequence YPYDVPDYA, which serves as a well-defined linear epitope. This sequence is recognized by monoclonal anti-HA antibodies, allowing for selective identification and manipulation of HA-tagged proteins in complex biological samples (https://labpe.com/index.php?g=Wap&m=Article&a=detail&id=79). The HA tag is not naturally present in most host proteomes, minimizing background binding and enhancing detection specificity. In studies of protein-protein interactions, post-translational modifications, and signaling networks, the HA peptide tag enables robust and reproducible capture of target proteins, including those involved in ubiquitin ligase pathways (https://doi.org/10.1002/advs.202504704).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide functions as an epitope tag by binding competitively to anti-HA antibodies. When fused to a protein of interest, the HA tag enables antibody-based detection, immunoprecipitation, or purification. During immunoprecipitation workflows, synthetic HA peptide can be introduced to competitively displace HA-tagged proteins from antibody-conjugated solid supports, allowing gentle and specific elution (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html). This competitive binding is highly sequence-specific; the nine-residue HA tag fits precisely within the antibody’s paratope, minimizing off-target effects (https://labpe.com/index.php?g=Wap&m=Article&a=detail&id=108). The high solubility of the HA peptide ensures rapid equilibration and effective competition in diverse buffer systems, including those used for protein-protein interaction and ubiquitination assays (https://pamidronatedisodium.com/index.php?g=Wap&m=Article&a=detail&id=15293). APExBIO’s A6004 HA Peptide’s >98% purity further ensures consistent performance in these sensitive applications.

Evidence & Benchmarks

• APExBIO’s Influenza Hemagglutinin (HA) Peptide (A6004) achieves >98% purity, as confirmed by both HPLC and mass spectrometry analyses (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html).
• The HA tag (YPYDVPDYA) is a validated epitope for monoclonal antibody recognition, supporting routine use in immunoprecipitation, pull-down, and western blotting assays (https://labpe.com/index.php?g=Wap&m=Article&a=detail&id=79).
• Solubility metrics: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water, ensuring compatibility with a wide range of experimental buffers (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html).
• Competitive binding of synthetic HA peptide enables efficient elution of HA-tagged proteins from anti-HA magnetic beads or conventional antibodies (https://pamidronatedisodium.com/index.php?g=Wap&m=Article&a=detail&id=15293).
• The HA tag has been central in dissecting protein-protein interactions in ubiquitin ligase pathways, as demonstrated in mechanistic studies of E3 ligase NEDD4L and PRMT5 (https://doi.org/10.1002/advs.202504704).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is extensively utilized in molecular biology for:

• Immunoprecipitation (IP) and co-immunoprecipitation (co-IP) assays involving HA-tagged fusion proteins.
• Affinity purification workflows for recombinant proteins.
• Protein-protein interaction mapping, including studies of E3 ligase and ubiquitin signaling networks (https://doi.org/10.1002/advs.202504704).
• Protein detection via western blot, immunofluorescence, and ELISA using anti-HA antibodies.
• Competitive elution protocols, where excess HA peptide is used to gently release HA-tagged proteins from antibody supports.

This article extends the mechanistic scope described in Translating Mechanistic Insight into Practice: The Influenza Hemagglutinin (HA) Peptide by delineating quantitative solubility and purity benchmarks for the APExBIO A6004 peptide.

For workflows focusing on the dissection of E3 ligase function and ubiquitin signaling, this article builds on Precision Tool for Ubiquitin Signaling by providing recent benchmarks in protein-protein interaction and cancer pathway studies.

Common Pitfalls or Misconceptions

• The HA tag does not confer enzymatic activity or alter the function of the fusion protein; it serves solely as an epitope tag.
• Excessive HA peptide can disrupt downstream detection if not fully removed post-elution.
• Not all anti-HA antibodies have identical affinity or specificity; experimental validation is recommended.
• The HA tag sequence (YPYDVPDYA) should be synthesized precisely; substitutions reduce antibody recognition.
• Peptide solutions are not recommended for long-term storage; lyophilized peptide should be stored desiccated at -20°C for stability.

Workflow Integration & Parameters

In IP or protein purification workflows, HA-tagged fusion proteins are incubated with immobilized anti-HA antibodies. Elution is achieved by adding synthetic HA peptide at concentrations typically ranging from 1 to 2 mg/mL, depending on sample complexity and antibody affinity. The high solubility of the peptide across organic and aqueous solvents enables its integration into standard and denaturing buffers. For protein-protein interaction studies, the specificity of the HA tag allows multiplexing with other epitope tags (e.g., FLAG, Myc), facilitating multi-component complex analysis. APExBIO recommends storing the lyophilized peptide at -20°C and avoiding repeated freeze-thaw cycles for optimal activity (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html).

For advanced strategies in exosome pathway studies and ubiquitination research, see Precision Tag for E3 Ligase Mechanisms, which the present article updates with solubility and purity data relevant to next-generation immunoprecipitation technologies.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a foundational tool in molecular biology, enabling high-specificity detection and purification of fusion proteins. APExBIO’s A6004 product delivers benchmark solubility and purity, supporting applications from basic protein interaction mapping to translational research in cancer signaling. Future developments may include engineered HA variants for multiplexed detection or integration into automated platforms. Researchers should select validated, high-purity peptides and rigorously control for antibody compatibility to ensure reproducible results.